BIOTECHNOLOGY giant Biogen
has drawn takeover interest
from drug companies Merck and
Allergan, raising the prospect of yet
another huge acquisition within the
health-care industry, according to a
report in the Wall Street Journal.
Communications at this stage
were said to be “informal and
preliminary”, and by no means
indicative of a definite result.
Biogen shares closed up 9.4% on
the news of talks, the report said.The above article was sent to subscribers in Pharmacy Daily's issue from 04 Aug 16 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 04 Aug 16
MONTU Group, its subsidiary Alternaleaf Pty Ltd, and their common director Christopher Strauch are facing legal action by the Therapeutic Goods Administration (TGA) in the Federal Court of Australia for alleged unlawful advertising on the effectiveness of their medicinal cannabis products.
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.